Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Actuate Therapeutics Inc.
Incyte Corporation
Eli Lilly and Company
Novartis
BeiGene
Nurix Therapeutics, Inc.
M.D. Anderson Cancer Center
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Puma Biotechnology, Inc.
Canadian Cancer Trials Group
Nektar Therapeutics
AbbVie
AbbVie
AbbVie
Clovis Oncology, Inc.
AbbVie
New Mexico Cancer Research Alliance
National Cancer Institute (NCI)
Amgen